DISCOUNT-ZERTIFIKAT - AMGEN | Market Closed - BOERSE MUENCHEN 20:46:53 17/05/2024 BST | ||
| 21.11 EUR | 0.00% |
|
| Current month | +1.10% | ||
| 1 month | +2.43% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 17/05/24 | 21.11 | 0.00% |
| 16/05/24 | 21.11 | +0.09% |
| 15/05/24 | 21.09 | -0.28% |
| 14/05/24 | 21.15 | -0.14% |
| 13/05/24 | 21.18 | -0.24% |
Real-time BOERSE MUENCHEN
Last update May 17, 2024 at 08:46 pm
More quotesStatic data
| Product type | Discount Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HC8RCQ |
| ISIN | DE000HC8RCQ7 |
| Date issued | 16/08/2023 |
| Maturity | 20/12/2024 (216 Days) |
| Parity | 10 : 1 |
| Emission price | 19.43 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 21.29 € |
|---|---|
| Lowest since issue | 19.26 € |
| Spread | 0.01 € |
| Spread % | 0.05% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
312.5
USD
Average target price
314.1
USD
Spread / Average Target
+0.51%
- Stock Market
- Certificates
- Certificat
